• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解决中低收入国家抗菌药物耐药问题的路线图:从印度喀拉拉邦公私参与和共同设计的抗菌药物管理方案中吸取的经验教训。

A road-map for addressing antimicrobial resistance in low- and middle-income countries: lessons learnt from the public private participation and co-designed antimicrobial stewardship programme in the State of Kerala, India.

机构信息

Amrita Institute of Medical Sciences, Amrita Vishwavidyapeetham, Kochi, India.

NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College, London, UK.

出版信息

Antimicrob Resist Infect Control. 2021 Feb 11;10(1):32. doi: 10.1186/s13756-020-00873-9.

DOI:10.1186/s13756-020-00873-9
PMID:33573697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7878026/
Abstract

BACKGROUND

The global concern over antimicrobial resistance (AMR) is gathering pace. Low- and middle-income countries (LMICs) are at the epicentre of this growing public health threat and governmental and healthcare organizations are at different stages of implementing action plans to tackle AMR. The South Indian state of Kerala was one of the first in India to implement strategies and prioritize activities to address this public health threat.

STRATEGIES

Through a committed and collaborative effort from all healthcare related disciplines and its professional societies from both public and private sector, the Kerala Public Private Partnership (PPP) has been able to deliver a state-wide strategy to tackle AMR A multilevel strategic leadership model and a multilevel implementation approach that included developing state-wide antibiotic clinical guidelines, a revision of post-graduate and undergraduate medical curriculum, and a training program covering all general practitioners within the state the PPP proved to be a successful model for ensuring state-wide implementation of an AMR action plan. Collaborative work of multi-professional groups ensured co-design and development of disease based clinical treatment guidelines and state-wide infection prevention policy. Knowledge exchange though international and national platforms in the form of workshops for sharing of best practices is critical to success. Capacity building at both public and private institutions included addressing practical and local solutions to the barriers e.g. good antibiotic prescription practices from primary to tertiary care facility and infection prevention at all levels.

CONCLUSION

Through 7 years of stakeholder engagement, lobbying with government, and driving change through co-development and implementation, the PPP successfully delivered an antimicrobial stewardship plan across the state. The roadmap for the implementation of the Kerala PPP strategic AMR plan can provide learning for other states and countries aiming to implement action plans for AMR.

摘要

背景

全球对抗微生物药物耐药性(AMR)的关注度正在不断提高。中低收入国家(LMICs)正处于这一日益严重的公共卫生威胁的中心,政府和医疗保健组织在实施应对 AMR 的行动计划方面处于不同阶段。印度南部的喀拉拉邦是印度最早实施应对这一公共卫生威胁的战略和优先活动的邦之一。

策略

通过所有医疗保健相关学科以及来自公私部门的专业协会的共同努力和协作,喀拉拉邦公私合作伙伴关系(PPP)成功实施了一项全州范围的战略来应对 AMR。该战略采用了多层次的战略领导模式和多层次的实施方法,包括制定全州范围的抗生素临床指南、修订研究生和本科医学课程,以及涵盖全州所有全科医生的培训计划。PPP 被证明是确保全州范围内实施 AMR 行动计划的成功模式。多专业小组的协作工作确保了基于疾病的临床治疗指南和全州范围的感染预防政策的共同设计和制定。通过国际和国家平台以研讨会形式进行知识交流,分享最佳实践,对成功至关重要。公共和私营机构的能力建设包括解决从初级保健到三级保健机构的合理抗生素处方实践和各级感染预防方面的实际和本地障碍。

结论

通过 7 年的利益相关者参与、与政府的游说以及通过共同制定和实施推动变革,PPP 成功地在全州范围内实施了抗菌药物管理计划。喀拉拉邦 PPP 战略 AMR 计划的实施路线图可以为其他旨在实施 AMR 行动计划的邦和国家提供借鉴。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06b8/7879609/c96673c00930/13756_2020_873_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06b8/7879609/947c84a0f75f/13756_2020_873_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06b8/7879609/c96673c00930/13756_2020_873_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06b8/7879609/947c84a0f75f/13756_2020_873_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06b8/7879609/c96673c00930/13756_2020_873_Fig2_HTML.jpg

相似文献

1
A road-map for addressing antimicrobial resistance in low- and middle-income countries: lessons learnt from the public private participation and co-designed antimicrobial stewardship programme in the State of Kerala, India.解决中低收入国家抗菌药物耐药问题的路线图:从印度喀拉拉邦公私参与和共同设计的抗菌药物管理方案中吸取的经验教训。
Antimicrob Resist Infect Control. 2021 Feb 11;10(1):32. doi: 10.1186/s13756-020-00873-9.
2
Building resilient and responsive research collaborations to tackle antimicrobial resistance-Lessons learnt from India, South Africa, and UK.建立有弹性和响应能力的研究合作关系,以应对抗微生物药物耐药性——来自印度、南非和英国的经验教训。
Int J Infect Dis. 2020 Nov;100:278-282. doi: 10.1016/j.ijid.2020.08.057. Epub 2020 Aug 27.
3
Dental antibiotic policies, stewardship, and implementation in India: A policy document analysis.印度的牙科抗生素政策、管理和实施:政策文件分析。
Community Dent Oral Epidemiol. 2024 Dec;52(6):844-860. doi: 10.1111/cdoe.12989. Epub 2024 Jun 18.
4
Coverage of policies to improve antimicrobial stewardship in human medicine in low and middle income countries: results from the Global Survey of Experts on Antimicrobial Resistance.改善中低收入国家人类医学中抗菌药物管理政策的覆盖范围:来自全球抗菌药物耐药性专家调查的结果。
BMC Public Health. 2024 Aug 23;24(1):2297. doi: 10.1186/s12889-024-19542-2.
5
Opportunities and barriers to implementing antibiotic stewardship in low and middle-income countries: Lessons from a mixed-methods study in a tertiary care hospital in Ethiopia.在中低收入国家实施抗生素管理的机遇与障碍:来自埃塞俄比亚一家三级护理医院的混合方法研究的经验教训。
PLoS One. 2018 Dec 20;13(12):e0208447. doi: 10.1371/journal.pone.0208447. eCollection 2018.
6
Revisions in TB programme - boon or bane? A qualitative study exploring barriers and facilitators among health care workers in private and public sector, Kerala.结核项目的修订——是福还是祸?一项在喀拉拉邦私立和公立部门的卫生保健工作者中,探索障碍和促进因素的定性研究。
Indian J Tuberc. 2021 Jul;68(3):356-362. doi: 10.1016/j.ijtb.2020.12.002. Epub 2020 Dec 13.
7
Combating antibiotic resistance using guidelines and enhanced stewardship in Kenya: a protocol for an implementation science approach.利用指南和强化管理来对抗肯尼亚的抗生素耐药性:实施科学方法的方案。
BMJ Open. 2020 Mar 31;10(3):e030823. doi: 10.1136/bmjopen-2019-030823.
8
Understanding the complex relationships among actors involved in the implementation of public-private mix (PPM) for TB control in India, using social theory.运用社会理论理解印度实施结核公私混合(PPM)控制中涉及的各行为体之间复杂的关系。
Int J Equity Health. 2018 Jun 7;17(1):73. doi: 10.1186/s12939-018-0785-1.
9
Coverage of antimicrobial resistance in the revised indian medical curriculum: Lip service only?修订后的印度医学课程中对抗菌素耐药性的涵盖:只是口惠而实不至?
Educ Health (Abingdon). 2020 May-Aug;33(2):70-73. doi: 10.4103/efh.EfH_251_19.
10
A review of animal health and drug use practices in India, and their possible link to antimicrobial resistance.印度动物健康和药物使用情况综述及其与抗微生物药物耐药性的可能联系。
Antimicrob Resist Infect Control. 2020 Jul 8;9(1):103. doi: 10.1186/s13756-020-00760-3.

引用本文的文献

1
Assessment of antibiotic utilization patterns in an Indian Level-1 Trauma Center: a pilot study exploring days of antibiotic spectrum coverage and defined daily doses using WHO AWaRe classification trends.印度一级创伤中心抗生素使用模式评估:一项探索抗生素谱覆盖天数及使用世界卫生组织药物应用的解剖学治疗学及化学分类系统(AWaRe)分类趋势的限定日剂量的试点研究。
Front Antibiot. 2025 Jul 15;4:1578217. doi: 10.3389/frabi.2025.1578217. eCollection 2025.
2
Identifying context-specific determinants to inform improvement of antimicrobial stewardship implementation in healthcare facilities in Asia: results from a scoping review and web-based survey among local experts.确定特定背景下的决定因素以促进亚洲医疗机构抗菌药物管理实施的改进:一项针对当地专家的范围综述和基于网络的调查结果
BMJ Open Qual. 2025 May 6;14(2):e003074. doi: 10.1136/bmjoq-2024-003074.
3

本文引用的文献

1
The impact of stringent prescription-only antimicrobial sale regulation (Schedule H1) in India: an interrupted time series analysis, 2008-18.印度严格的仅凭处方销售抗菌药物规定(H1附表)的影响:一项2008 - 2018年的中断时间序列分析
JAC Antimicrob Resist. 2020 Oct 3;2(3):dlaa076. doi: 10.1093/jacamr/dlaa076. eCollection 2020 Sep.
2
What was right about Kerala's response to the COVID-19 pandemic?喀拉拉邦应对新冠疫情的措施中有哪些是正确的?
BMJ Glob Health. 2020 Jul;5(7). doi: 10.1136/bmjgh-2020-003212.
3
India under COVID-19 lockdown.处于新冠疫情封锁下的印度。
Collaboration between local authorities and civil society organisations for improving health: a scoping review.地方当局与民间社会组织为改善健康状况而开展的合作:一项范围界定审查
BMJ Open. 2025 Mar 25;15(3):e092525. doi: 10.1136/bmjopen-2024-092525.
4
Approaches, enablers and barriers to govern the private sector in health in low- and middle-income countries: a scoping review.中低收入国家治理私营部门参与卫生事务的方法、促进因素和障碍:范围综述。
BMJ Glob Health. 2024 Nov 13;8(Suppl 5):e015771. doi: 10.1136/bmjgh-2024-015771.
5
Power Relations in Optimisation of Therapies and Equity in Access to Antibiotics (PROTEA) Study: investigating the intersection of socio-economic and cultural drivers on antimicrobial resistance (AMR) and its influence on healthcare access and health-providing behaviours in India and South Africa.优化治疗中的权力关系与抗生素获取公平性(PROTEA)研究:调查社会经济和文化驱动因素在印度和南非对抗菌素耐药性(AMR)的交叉影响及其对医疗服务获取和医疗行为的影响
Wellcome Open Res. 2024 Jul 24;9:400. doi: 10.12688/wellcomeopenres.20193.1. eCollection 2024.
6
Rationalizing irrational prescribing-infection-related attitudes and practices across paediatric surgery specialties in a hospital in South India.合理化印度南部一家医院儿科手术各专科中与感染相关的不合理处方、态度及做法
JAC Antimicrob Resist. 2024 Jul 13;6(4):dlae105. doi: 10.1093/jacamr/dlae105. eCollection 2024 Aug.
7
Challenges in implementing an Antimicrobial Stewardship Program (ASP) in developing countries.在发展中国家实施抗菌药物管理计划(ASP)面临的挑战。
J Postgrad Med. 2024 Oct 1;70(4):185-190. doi: 10.4103/jpgm.jpgm_228_24. Epub 2024 Jul 10.
8
Community pharmacists as antimicrobial resistance stewards: a narrative review on their contributions and challenges in low- and middle-income countries.社区药剂师作为抗菌药物耐药性管理者:在中低收入国家的贡献和挑战的叙述性综述。
J Pharm Pharm Sci. 2024 Jun 13;27:12721. doi: 10.3389/jpps.2024.12721. eCollection 2024.
9
Drivers of inappropriate use of antimicrobials in South Asia: A systematic review of qualitative literature.南亚抗菌药物不当使用的驱动因素:定性文献的系统评价
PLOS Glob Public Health. 2024 Apr 4;4(4):e0002507. doi: 10.1371/journal.pgph.0002507. eCollection 2024.
10
Policy entrepreneurs are integral in efforts to curb antimicrobial resistance in low and middle income countries.政策企业家在中低收入国家遏制抗菌药物耐药性的努力中不可或缺。
Front Public Health. 2024 Mar 12;12:1292660. doi: 10.3389/fpubh.2024.1292660. eCollection 2024.
Lancet. 2020 Apr 25;395(10233):1315. doi: 10.1016/S0140-6736(20)30938-7.
4
India's National Action Plan for antimicrobial resistance - An overview of the context, status, and way ahead.印度抗菌药物耐药性国家行动计划——背景、现状及未来方向概述
J Family Med Prim Care. 2019 Jun;8(6):1828-1834. doi: 10.4103/jfmpc.jfmpc_275_19.
5
Policy document on antimicrobial stewardship practices in India.印度抗菌药物管理政策文件。
Indian J Med Res. 2019 Feb;149(2):180-184. doi: 10.4103/ijmr.IJMR_147_18.
6
Tracking global trends in the effectiveness of antibiotic therapy using the Drug Resistance Index.利用耐药指数追踪抗生素治疗效果的全球趋势。
BMJ Glob Health. 2019 Apr 11;4(2):e001315. doi: 10.1136/bmjgh-2018-001315. eCollection 2019.
7
Implementation and Impact of an Antimicrobial Stewardship Program at a Tertiary Care Center in South India.印度南部一家三级医疗中心抗菌药物管理计划的实施与影响
Open Forum Infect Dis. 2018 Nov 8;6(4):ofy290. doi: 10.1093/ofid/ofy290. eCollection 2019 Apr.
8
Antimicrobial Resistance: Progress in the Decade since Emergence of New Delhi Metallo-β-Lactamase in India.抗微生物药物耐药性:自印度出现新德里金属β-内酰胺酶以来十年间的进展
Indian J Community Med. 2019 Jan-Mar;44(1):4-8. doi: 10.4103/ijcm.IJCM_217_18.
9
Barriers for involvement of private doctors in RNTCP - Qualitative study from Kerala, India.印度喀拉拉邦关于私人医生参与国家结核病控制规划的障碍——定性研究
J Family Med Prim Care. 2019 Jan;8(1):160-165. doi: 10.4103/jfmpc.jfmpc_208_18.
10
Paying for Hemodialysis in Kerala, India: A Description of Household Financial Hardship in the Context of Medical Subsidy.印度喀拉拉邦的血液透析费用:医疗补贴背景下的家庭经济困难描述
Kidney Int Rep. 2018 Dec 20;4(3):390-398. doi: 10.1016/j.ekir.2018.12.007. eCollection 2019 Mar.